Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 63,712Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Sanofi

02 1Biocon

03 58Novo Nordisk

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

INSULIN ASPART

Brand Name : TRURAPI

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging :

Approval Date :

Application Number : 2506564

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

02

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

INSULIN ASPART

Brand Name : TRURAPI

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging :

Approval Date :

Application Number : 2506572

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

03

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

INSULIN ASPART

Brand Name : TRURAPI

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging :

Approval Date :

Application Number : 2529254

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN ASPART RECOMBINANT

Brand Name : NOVOLOG

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 1000 UNITS/10ML (100 UNITS/ML)

Packaging :

Approval Date :

Application Number : 20986

Regulatory Info :

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN ASPART RECOMBINANT

Brand Name : NOVOLOG PENFILL

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)

Packaging :

Approval Date :

Application Number : 20986

Regulatory Info :

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN ASPART RECOMBINANT

Brand Name : NOVOLOG FLEXPEN

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)

Packaging :

Approval Date :

Application Number : 20986

Regulatory Info :

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN ASPART RECOMBINANT

Brand Name : NOVOLOG INNOLET

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)

Packaging :

Approval Date :

Application Number : 20986

Regulatory Info :

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN ASPART RECOMBINANT

Brand Name : NOVOLOG FLEXTOUCH

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)

Packaging :

Approval Date :

Application Number : 20986

Regulatory Info :

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT

Brand Name : NOVOLOG MIX 70/30

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 700 UNITS/10ML; 300 UNITS/10ML (70 UNITS/ML; 30 UNITS/ML)

Packaging :

Approval Date :

Application Number : 21172

Regulatory Info :

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT

Brand Name : NOVOLOG MIX 70/30 PENFILL

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)

Packaging :

Approval Date :

Application Number : 21172

Regulatory Info :

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT

Brand Name : NOVOLOG MIX 70/30 PENFILL

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)

Packaging :

Approval Date :

Application Number : 21172

Regulatory Info :

Registration Country : USA

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT

Brand Name : NOVOLOG MIX 70/30 FLEXPEN

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)

Packaging :

Approval Date :

Application Number : 21172

Regulatory Info :

Registration Country : USA

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT

Brand Name : NOVOLOG MIX 50/50

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 50 UNITS/ML;50 UNITS/ML

Packaging :

Approval Date :

Application Number : 21810

Regulatory Info :

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN ASPART; INSULIN DEGLUDEC

Brand Name : RYZODEG 70/30

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 90 UNITS/3ML;210 UNITS/3ML (30 UNITS/ML;70 UNITS/ML)

Packaging :

Approval Date :

Application Number : 203313

Regulatory Info :

Registration Country : USA

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN ASPART

Brand Name : FIASP

Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 1000 UNITS/10ML (100 UNITS/ML)

Packaging :

Approval Date :

Application Number : 208751

Regulatory Info :

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN ASPART

Brand Name : FIASP FLEXTOUCH

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)

Packaging :

Approval Date :

Application Number : 208751

Regulatory Info :

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN ASPART

Brand Name : FIASP PENFILL

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)

Packaging :

Approval Date :

Application Number : 208751

Regulatory Info :

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Novorapid

Brand Name : Novorapidfill

Dosage Form : Insulin Aspart 300Iu 3Ml 5 Units Parenteral Use

Dosage Strength : 5 cartridges SC 300 IU 3 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Novorapid

Brand Name : Novorapid Flexpen

Dosage Form : Insulin Aspart 300Iu 3Ml 5 Units Parenteral Use

Dosage Strength : 5 cartridges SC in pens preriemp 3 ml 100 U/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Novorapid

Brand Name : Novomix

Dosage Form : Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 30/70 300Iu 3Ml 5 Units Parenteral Use

Dosage Strength : FLEXPEN 5 cartridges SC in pens preriemp 3 ml 100 IU/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank